SYNACT.ST STO
SynAct Pharma AB
1W: +2.9%
1M: +2.1%
3M: -7.8%
YTD: -13.6%
1Y: -3.5%
3Y: -82.2%
5Y: -83.8%
kr 17.80 ($1.77)
+0.62 (+3.61%)
Weekly Expected Move ±6.3%
kr 16
kr 17
kr 18
kr 19
kr 20
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$221M
-18.5% ▼
5Y CAGR: +59.2%
Total Liabilities
$50M
-10.9% ▼
5Y CAGR: +54.4%
Shareholders Equity
$170M
-20.5% ▼
5Y CAGR: +60.7%
Cash & Investments
$53M
-12.7% ▼
5Y CAGR: +29.7%
Total Debt
$2M
-4.0% ▼
Net Debt
-$52M
+13.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $24M | $108M | $62M | $61M | $53M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $24M | $108M | $62M | $61M | $53M |
| Net Receivables | $11M | $15M | $12M | $6M | $13M |
| Inventory | $246K | $0 | $0 | $0 | $0 |
| Other Current Assets | -$246K | $0 | $0 | $8M | -$1K |
| Total Current Assets | $35M | $140M | $75M | $94M | $71M |
| Property, Plant & Equip. | $3M | $2M | $660K | $2M | $1M |
| Goodwill & Intangibles | $0 | $0 | $152M | $155M | $148M |
| Long-Term Investments | $75K | $90K | $46K | $51K | $135K |
| Other Non-Current Assets | $199K | $180K | $94K | $20M | $0 |
| Total Non-Current Assets | $3M | $2M | $153M | $177M | $149M |
| Total Assets | $38M | $143M | $228M | $271M | $221M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $5M | $10M | $17M | $9M |
| Short-Term Debt | $979K | $1M | $579K | $595K | $0 |
| Deferred Revenue | $10M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$325K | $6M | $4M | $10M | $11M |
| Total Current Liabilities | $15M | $15M | $25M | $28M | $22M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $595K |
| Other Non-Current Liab. | $0 | $0 | $9M | $8M | $11M |
| Total Non-Current Liabilities | $2M | $1M | $27M | $28M | $29M |
| Total Liabilities | $18M | $16M | $52M | $56M | $50M |
| — Equity — | |||||
| Common Stock | $3M | $4M | $4M | $6M | $7M |
| Retained Earnings | -$176M | -$275M | -$491M | -$573M | -$684M |
| Accumulated OCI | -$399K | $3M | $16M | $19M | $12M |
| Total Stockholders Equity | $21M | $127M | $176M | $214M | $170M |
| Total Liabilities & Equity | $38M | $143M | $228M | $271M | $221M |
| — Key Metrics — | |||||
| Total Debt | $3M | $2M | $637K | $2M | $2M |
| Net Debt | -$21M | -$106M | -$62M | -$59M | -$52M |
| Total Investments | $75K | $90K | $46K | $51K | $135K |